高级检索
当前位置: 首页 > 详情页

Regulatory Role of the RNA N-6-Methyladenosine Modification in Immunoregulatory Cells and Immune-Related Bone Homeostasis Associated With Rheumatoid Arthritis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China, [2]Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China, [3]School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China, [4]Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China, [5]Clinical Medical School (China-Japan Friendship Hospital), Beijing University of Chinese Medicine, Beijing, China, [6]Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan, [7]Department of Plastic Surgery, China-Japan Friendship Hospital, Beijing, China, [8]Department of Emergency, China-Japan Friendship Hospital, Beijing, China
出处:
ISSN:

关键词: RNA N-6-methyladenosine immunoregulatory cells bone homeostasis rheumatoid arthritis epigenetics

摘要:
Rheumatoid arthritis (RA) is a systemic autoimmune disease for which the etiology has not been fully elucidated. Previous studies have shown that the development of RA has genetic and epigenetic components. As one of the most highly abundant RNA modifications, the N-6-methyladenosine (m(6)A) modification is necessary for the biogenesis and functioning of RNA, and modification aberrancies are associated with various diseases. However, the specific functions of m(6)A in the cellular processes of RA remain unclear. Recent studies have revealed the relationship between m(6)A modification and immune cells associated with RA. Therefore, in this review, we focused on discussing the functions of m(6)A modification in the regulation of immune cells and immune-related bone homeostasis associated with RA. In addition, to gain a better understanding of the progress in this field of study and provide the proper direction and suggestions for further study, clinical application studies of m(6)A modification were also summarized.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2020]版
大类 | 2 区 生物
小类 | 2 区 发育生物学 3 区 细胞生物学
最新[2025]版:
大类 | 2 区 生物学
小类 | 2 区 发育生物学 3 区 细胞生物学
JCR分区:
出版当年[2019]版:
Q1 DEVELOPMENTAL BIOLOGY Q2 CELL BIOLOGY
最新[2023]版:
Q1 DEVELOPMENTAL BIOLOGY Q2 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2019版] 出版当年五年平均[2015-2019] 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China, [2]Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China,
共同第一作者:
通讯作者:
通讯机构: [1]Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China, [2]Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China, [8]Department of Emergency, China-Japan Friendship Hospital, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)